Slide 1First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their…

This package insert is continually updated: please read carefully before using a new pack. In case of any question, please contact your physician or pharmacist. TAXOTERE…

Slide 1 Neoplasie del Colon-retto Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Slide 9 Slide 10 Slide 11 Slide 12 Slide 13 Slide 14 Slide 15 Slide 16 Slide 17…

Slide 1 Updates in the Treatment of Breast cancer Mohammad Jahanzeb, MD, FACP Professor of Clinical Medicine, Hematology-Oncology Director, UM Sylvester Deerfield Campus…

Slide 1 Breast Plenary Abstracts How Do These Studies Impact Clinical Practice Today and in the Years Ahead? Presented By Eric Winer at 2014 ASCO Annual Meeting Slide 2 First…

Slide 1 There is more to clinical trials than chemotherapy and survival Alan P. Venook, M.D. University of California, SF Slide 2 ASCO Colorectal Cancer Poster Discussion…

Axel Grothey Professor of Oncology Mayo Clinic, Rochester, Minnesota, USA Vice Chair and Director of Cancer Treatment of the North Central Cancer Treatment Group (NCCTG)…

Xeloda for the adjuvant treatment of stage III colon cancer Chris Twelves University of Leeds and Bradford NHS Trust UK X-ACT trial in adjuvant treatment of stage III colon…

Abstract 8504: E4697: Phase III Cooperative Group Study of Yeast Derived GM-CSF vs Placebo as Adjuvant Treatment of Patients with Completely Resected Stage III-IV Melanoma…

Emerging Trends in Biosimilars and Biologics Prof. Dr. Kaiser Jamil Bhagwan Mahavir Medical Research Centre, Hyderabad -TS E-mail: [email protected] conference presentation-Dr.…